Literature DB >> 486894

Recovery from sublethal damage by acutely hypoxic tumour cells in vivo and in vitro.

N J McNally, K C George, J de Ronde.   

Abstract

The ability of acutely hypoxic tumour cells to recover from sublethal damage following irradiation in vivo and in vitro has been measured using a single tumour system. The methods of assay were tumour growth delay, local tumour control and tumour cell survival in vitro following treatment in vivo or in vitro. Tumours in vivo or cells in vitro rendered acutely hypoxic during irradiation were irradiated with either single doses or two doses 24 hours apart. Cells left in situ had a greater capacity for recovery than those treated either in vivo or in vitro and then assayed in vitro. It is suggested that tumours may not show a systematically reduced capacity for recovery relative to normal tissues, unless chronically hypoxic tumour cells have a reduced capacity for recovery and determine the response. However, the results imply that deductions as to the ability of tumour cells to recover from sublethal damage (whether chronically hypoxic or not), which rely on in vitro assays, may underestimate the extent of recovery.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486894     DOI: 10.1259/0007-1285-52-620-642

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  3 in total

Review 1.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Radiobiological studies of tumours in situ compared with cell survival.

Authors:  N J McNally; J de Ronde
Journal:  Br J Cancer Suppl       Date:  1980-04

3.  Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.

Authors:  N J McNally; M Hinchliffe; J de Ronde
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.